Paper 59 - INTERNATIONAL MULTICENTER RETROSPECTIVE STUDY FROM THE ULTRA-RARE SARCOMA WORKING GROUP ON LOW-GRADE FIBROMYXOID SARCOMA AND SCLEROSING EPITHELIOD FIBROSARCOMA: OUTCOME OF PRIMARY LOCALISED DISEASE

Author(s)

• 

  Silvia Stacchiotti, MD (she/her/hers)

  Consultant
  Department of Medical Oncology 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
  Milano, Lombardia, Italy

  Slides

Presenter(s)

• 

  Claudia Giani, MD

  Medical Oncology resident
  Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
  Milan, Lombardia, Italy

Co-Author(s)

• 

  Silva Ljevar, MSc (she/her/hers)

  Reserach Fellow
  Unit of Biostatistics for Clinical Research Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
  Milan, Lombardia, Italy
• 

  Alexander J. Lazar, MD, PhD (he/him/his)

  Professor of Pathology & Genomic Medicine
  The University of Texas MD Anderson Cancer Center
  Houston, Texas, United States
• 

  Costanza Figura (she/her/hers)

  Medical student
  Department of Surgery, Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
  Milano, Lombardia, Italy
• AN

  Andrea Napolitano, MD (he/him/his)

  Consultant Medical Oncologist
  The Royal Marsden NHS, London, UK
  London, England, United Kingdom
• 

  Elizabeth Connolly, MD (she/her/hers)

  Research Fellow
  Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, Australia. Faculty of medicine and health, University of Sydney, Sydney, Australia.
  Sydney, New South Wales, Australia
• 

  Emanuela Palmerini, MD, PhD (she/her/hers)

  Consultant Medical Oncologist
  IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
  Bologna, Emilia-Romagna, Italy
• RS

  Roberto Scanferla, MD

  Orthopedics Oncology and Reconstructive Surgery Unit, Azienda Ospedaliero Universitaria Careggi, Florence, Italy
  Firenze, Toscana, Italy
• 

  Jyoti Bajpai, MD, DM (she/her/hers)

  Professor
  Tata Memorial Centre,Homibhabha National University,Mumbai,India
  Mumbai, Maharashtra, India
• DW

  Daniel Wong, n/a

  Sir Charles Gairdner Hospital (SCGH), Australia
  Nedlands, Western Australia, Australia
• 

  Koichi Ogura, MD, PhD (he/him/his)

  Head
  National Cancer Center Hospital
  Tokyo, Tokyo, Japan
• 

  Chia-Chen Li, MD

  Attending physician
  National Taiwan University Cancer Center
  Taipei, Taipei, Taiwan (Republic of China)
• 

  Steven Bialick, DO

  Medical Oncologist
  Sylvester Comprehensive Cancer Center, University of Miami
  Deerfield Beach, Florida, United States
• 

  Alexander Lee, Consultant

  Consultant Medical Oncologist
  The Christie NHS Foundation Trust
  Manchester, England, United Kingdom
• 

  Yeh Chen Lee, MBBS BMedSci MPhil FRACP (she/her/hers)

  Dr
  Prince of Wales Hospital
  Randwick, New South Wales, Australia
• 

  Susie Bae, MBBS, MSc

  Medical Oncologist
  Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
  Melbourne, Victoria, Australia
• SB

  Sosipatros A. Boikos, MD

  Georgetown Lombardi Comprehensive Cancer Center
  Washington, District of Columbia, United States
• HK

  Hanna Koseła-Paterczyk, MD PhD

  Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology
  Warsaw, Mazowieckie, Poland
• AB

  Antonella Brunello, MD

  Department of Oncology, IRCCS Istituto Oncologico Veneto, Padua, Italy
  Padova, Veneto, Italy
• GB

  Giacomo Giulio Baldi, MD

  Medical Consultant
  Medical Oncology Department, "Santo Stefano" Hospital, Prato, Italy
  Prato, Toscana, Italy
• 

  Herbert Ho Fung Loong, MBBS(HK), PDipMDPath(HK), MRCP(UK), FRCP Edin, FHKCP, FHKAM(Medicine) (he/him/his)

  Clinical Associate Professor
  The Chinese University of Hong Kong
  Hong Kong, Hong Kong
• 

  Fernando Campos, MD (he/him/his)

  Medical Oncologist
  Medical Oncology Department, A.C.Camargo Cancer Center, São Paulo, SP, Brazil
  Sao Paulo, Sao Paulo, Brazil
• RM

  Robert Maki, MD, PhD, FACP, FASCO (he/him/his)

  Professor of Medicine, Member
  Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center (MSKCC)
  New York, New York, United States
• 

  Carlo M. Cicala, MD

  Medical Oncologist / PhD Fellow
  Vall d'Hebron Institute of Oncology
  Barcelona, Catalonia, Spain
• 

  Vladimir Andelkovic, MD

  Medical Oncologist
  Princess Alexandra Hospital (PAH), Australia
  Brisbane, Queensland, Australia
• MS

  Marta Sbaraglia, MD

  Department of Pathology, Azienda Ospedale-Università Padova, Padova, Italy
  Padova, Veneto, Italy
• 

  Inga-Marie Schaefer, MD (she/her/hers)

  Assistant Professor
  Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA
  Boston, Massachusetts, United States
• 

  Rosalba Miceli, MD, PhD (she/her/hers)

  Director of Unit of Biostatistics for Clinical Research
  Unit of Biostatistics for Clinical Research Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
  Milan, Lombardia, Italy
• 

  Alessandro Gronchi, MD, FSSO (he/him/his)

  Chief Sarcoma Service and Chair of the Department of Surgery
  Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
  Milan, Lombardia, Italy